---
figid: PMC9637655__fendo-13-984342-g002
pmcid: PMC9637655
image_filename: fendo-13-984342-g002.jpg
figure_link: /pmc/articles/PMC9637655/figure/f2/
number: Figure 2
figure_title: ''
caption: The benefits and drawbacks of altering cardiac O-GlcNAcylation. BCAA, branched-chain
  amino acid; FFA, free fatty acid; NOGPs, non-oxidative glucose pathways; K+, potassium;
  ROS, reactive oxygen species; CaMKII, calcium-calmodulin dependent protein kinase
  II; GATA4, GATA binding protein 4; ANP, atrial natriuretic peptide; PGC-1α, peroxisome
  proliferator-activated receptor-gamma coactivator-1α; OGT, O-GlcNAc transferase;
  OGA, O-GlcNAcase. Created with BioRender.com .
article_title: The dual role of the hexosamine biosynthetic pathway in cardiac physiology
  and pathophysiology.
citation: Megan Cairns, et al. Front Endocrinol (Lausanne). 2022;13:984342.
year: '2022'

doi: 10.3389/fendo.2022.984342
journal_title: Frontiers in Endocrinology
journal_nlm_ta: Front Endocrinol (Lausanne)
publisher_name: Frontiers Media S.A.

keywords:
- metabolism
- heart
- hexosamine biosynthetic pathway
- oxidative stress
- diabetes
- cardiac hypertrophy
- myocardial ischemia
- heart failure

---
